Development of a Novel IGF2BP1 Inhibitor as Metastasis-Specific Therapeutic Agent

Research output: Contribution to journalArticlepeer-review

1 Scopus citations
Original languageEnglish
Pages (from-to)S104-S105
JournalEuropean Journal of Cancer
Volume174
DOIs
StatePublished - Oct 2022

Cite this